rSIFN-co

BIOLOGICAL2 trials

Conditions

Carcinoma, HepatocellularCarcinoma, Non-Small-Cell LungCarcinoma, Renal CellColon CancerMalignancies Including Melanoma, Kidney, Lung, Colorectal, Prostate, Neuroendocrine TumorMelanoma

Phase 1

A Study of rSIFN-co in Subjects With Advanced Solid Tumors

CompletedNCT02387307

Sichuan Huiyang Life Science and Technology CorporationCarcinoma, Hepatocellular, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell +2

Start: 2013-07-31End: 2018-06-30Updated: 2019-09-27

Study of rSIFN-co for Patients With Advanced Solid Tumors

TerminatedNCT02464007

Sichuan Huiyang Life Science and Technology CorporationMalignancies Including Melanoma, Kidney, Lung, Colorectal, Prostate, Neuroendocrine Tumor

Start: 2016-01-31End: 2024-11-30Updated: 2025-02-25

rSIFN-co

Sponsors

Conditions

Phase 1